Lincoln Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

812.10

-1.45 (-0.18%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

812.10

-1.45 (-0.18%)
16:02 Dec 20

Quality

61/100
High Financial Strength

Valuation

56/100
Affordable Valuation

Technical

61/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	424.19	472.12	510.31	580.55	597.43
Operating Expenses +	337.01	376.64	421.1	480.65	498.3
Raw Material	193.74	232.15	245.64	284.03	301.32
Increase Decrease in Cost	3.99	-13.57	-4.24	-5.7	-18.11
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	60.74	70.47	93.16	102.9	108.35
Miscellaneous Expenses	219.16	234.93	223.82	265.24	106.74
Operating Profit	87.18	95.48	89.21	99.9	99.13
Other Income	5.66	10	22.47	34.42	38.43
Depreciation	7.56	8.09	9.17	10.62	11.94
Interest	1.56	1.45	2.03	1.46	1.44
Profit before tax and exceptio..	83.72	95.94	100.48	122.24	124.18
Exceptional Items	0	0	0	0	0
PBT	83.72	95.94	100.48	122.24	124.18
Provision for Taxation	21.47	26.58	27.58	28.94	27.55
Net Profit	62.25	69.36	72.9	93.3	96.64
NET Profit after MI	62.22	69.36	72.9	93.3	96.64
EPS	31.11	34.63	36.4	46.58	48.25
Operating Profit Margin (%)	20.55	20.22	17.48	17.21	16.59
Net Profit Margin (%)	14.67	14.69	14.29	16.07	16.18

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	49.80	49.80	49.50	49.80	50.50
FII	5.20	4.00	3.90	3.20	2.60
MF	0.00	0.00	0.00	0.00	0.00
Public	45.00	46.20	46.50	46.90	46.90
Others	0.00	0.00	0.00	0.00	0.00
Others	0.00	0.00	0.10	0.10	0.00